Results 121 to 130 of about 2,751,693 (208)

New tyrosine kinase inhibitors in chronic myeloid leukemia

open access: yesHaematologica, 2005
The deregulated activity of BCR-ABL tyrosine kinase originating from the t(9;22) chromosomal translocation has been shown to be necessary and sufficient for the transformed phenotype of chronic myeloid leukemia (CML) cells. This peculiarity has paved the
G Martinelli   +4 more
doaj  

NDRG3 regulates imatinib resistance by promoting β‑catenin accumulation in the nucleus in chronic myelogenous leukemia. [PDF]

open access: yesOncol Rep, 2023
Wang X   +12 more
europepmc   +1 more source

Molecular mechanisms of imatinib resistance in gastrointestinal stromal tumor with focus on microRNAs

open access: yes, 2014
Gastrointestinal stromal tumor (GIST) is mainly initialized by mutations in receptor tyrosine kinase genes KIT or PDGFRA. The development of imatinib, a small molecule inhibitor that targets these tyrosine kinase receptors, remarkably improved patient ...
Pinar Akcakaya (18668500)
core   +1 more source

Identification of Thiazolo[5,4-b]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance. [PDF]

open access: yesCancers (Basel), 2022
Nam Y   +8 more
europepmc   +1 more source

Imatinib Resistance and Other Diseases Targeted by Imatinib

open access: yes
This lecture from the iBioSeminars project is presented by Brian Druker of HHMI and the Oregon Health & Science University Cancer Institute. It describes how although the majority of patients with CML respond well to imatinib, a minority of patients ...
Druker, Brian J.
core   +1 more source

Alvespimycin Inhibits Heat Shock Protein 90 and Overcomes Imatinib Resistance in Chronic Myeloid Leukemia Cell Lines. [PDF]

open access: yesMolecules, 2023
Alves R   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy